Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q2 EBITDA At SEK 8.1 Million

July 12 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * HISTORIC PMA APPROVAL AND PROGRESS IN THE RESEARCH AND
DEVELOPMENT PORTFOLIO
    * Q2 EBITDA SEK 8.1 MILLION VERSUS SEK 8.1 MILLION YEAR AGO
    * Q2 NET SALES OF NON-DURABLE GOODS IN QUARTER AMOUNTED TO
SEK
50.5 MLN (42.2 MLN)
    * Q2 NET SALES SEK 56.4 MILLION VERSUS SEK 46.1 MILLION YEAR
AGO

Source text for Eikon:  ID:nWkr74y8fS 
Further company coverage:  XVIVO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))

Recent news on Xvivo Perfusion AB

See all news